HAI Europe Open Seminar 2012
11 videos • 80 views • by Health Action International Access to medical research data is an essential foundation of rational health care policy, and the consequences of restricting such access are the subject of growing debate. The HAI Europe Open Seminar explored this topic using the 2009 outbreak of H1N1 influenza (also known as the Mexican or Swine flu) as a case study, and then discussed the latest steps the EU institutions are taking to improve open access. The outbreak of H1N1 saw governments spend millions of Euros on antiviral medicines, although it later emerged that this decision was preceded by limited access to efficacy and safety data. What are EU institutions doing to open access to data to prevent such a situation from happening again, and what more should be done? The Open Seminar brought together key players of this debate, in order to stimulate a constructive discussion about transparency of medicines safety and efficacy data in Europe.